(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid, 98.0%, 10g

(1-(4-Bromophenyl)cyclobutyl)methanol, 95.0%, 250mg

2-Chloro-4-cyano-benzenesulfonyl chloride, 98.0%, 25g

4-isocyanatocyclohexene, 95.0%, 500mg

Methyl 4-amino-5-chlorothiophene-2-carboxylate, 95.0%, 1g

Long working distance plan phase 4x/0.13 IOS objective, working distance 10.75 mm

Piperazine dihydrochloride hydrate, 98%, 100g

(S)-2-(4-(2-Amino-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-yl)piperazin-1-yl)ethan-1-ol, 97%, 100mg

N-p-tolylformamide, 98%, 250mg

4-Fluoro-2-methoxyaniline hydrochloride, 95.0%, 5g

Single-use cuvettes fluorescence UV-transparent, 100 Piece(s)

3-(2,4-Dichlorophenyl)propan-1-ol, 96.0%, 1g

4-METHOXY-2-HYDROXYMETHYLPYRIDINE, 97.0%, 25g